Shift Bioscience

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Operator of a biotechnology company intended to develop simulation-guided cell rejuvenation therapies to address the diseases of aging. Shift Bioscience is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $30.5 million. It has raised $17.5 million.

Last price · $/share
—
Implied valuation
$30.5M
Total raised
$17.5M
Last round
—

Who backs Shift Bioscience?

13 investors
InvestorType
F-Prime CapitalVenture capital
Boost VCVenture capital
BGF (Financial Services)Growth equity
Meltwind Advisory—
Jonathan Milner—
Accelerate@Babraham—
DG Global Ventures—
Frame Shift Bio-Incubator—
Galloway (Construction and Engineering)—
Healthspan Capital—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Shift Bioscience investors

13 investors are on record for Shift Bioscience, including F-Prime Capital, Boost VC, BGF (Financial Services) and Meltwind Advisory.

Free account
More of Shift Bioscience with a free account
  • ·The complete investor list: 13 names
  • ·Watch Shift Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Shift Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View